LHRCDA:通过可学习的超图形重建来预测circRNA和药物敏感性之间的关联
Jingshuai Wang1, Jinmiao Song1, Hui Zhai2
1Department of Software, Xinjiang University, Urumqi, 830008, China.
Computational biology and chemistry
|October 25, 2025
概括
这项研究引入了一种新的可学习超图重建 (LHRCDA) 方法,用于预测循环RNA药物敏感性关联. 该方法有效地捕获了更高层次的结构信息,优于现有的模型来识别潜在的治疗点.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 循环RNAs (circRNAs) 在疾病发展和药物反应中至关重要,使其与药物的关联对了解疾病机制和找到治疗点具有重要意义.
- 传统的超图法在动态结构调整和提取高阶信息方面扎,限制了它们在复杂的生物网络分析中的有效性.
研究的目的:
- 开发一个先进的计算模型来预测circRNA-药物敏感性关联.
- 通过结合可学习的重建和分层映射来克服静态超图方法的局限性,以增强信息提取.
主要方法:
- 介绍了一个可学习的超图重建方法,用于circRNA-药物敏感性关联预测 (LHRCDA).
- 采用矩阵分解来实现超图初始化,然后采用可学习的重建机制来捕获更高阶结构信息.
- 利用分层超图映射和感知融合策略来整合异质图和超图视图,增强非线性交互建模.
主要成果:
- 与现有的最先进的方法相比,LHRCDA模型在预测circRNA药物敏感性关联方面表现优异.
- 通过超图表进行更高阶结构建模显著提高了预测准确性.
- 关于伏利诺斯塔特和塞图西马布的案例研究验证了该模型作为药物发现的可靠工具的潜力.
结论:
- 通过利用可学习的超图形重建和层次融合,LHRCDA方法有效地建模复杂的circRNA-药物相互作用.
- 这种方法提供了一个有前途的计算工具,用于识别新型circRNA药物敏感性关联,有助于阐明疾病机制和治疗目标的发现.
更多相关视频
10:27In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
2.0K
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.3K
相关概念视频
02:26Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
01:25Drug-Receptor Bonds
4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.2K